Endoscopic retrograde cholangiopancreatography (ERCP) outcomes can improve after further training for an individual already experienced in ERCP [0.03%]
内镜逆行胰胆管造影的结局在有经验的操作者接受进一步培训后可得到改善
J Choi,N Malik,D Drachman et al.
J Choi et al.
This study was carried out to assess the impact of therapeutic endoscopy training on the endoscopic retrograde cholangiopancreatography (ERCP) practice of a physician who was practicing ERCP for many years in a community setting in the Unit...
A Altinbas,J P Sowa,T Hasenberg et al.
A Altinbas et al.
Non-alcoholic fatty liver disease (NAFLD) is the liver manifestation of metabolic syndrome and frequently accompanied with obesity, insulin resistance, hyperlipidemia and hypertension. NAFLD comprises a variety of clinical conditions rangin...
A large multicenter study analysis of adverse events associated with single operator cholangiopancreatoscopy [0.03%]
单操作胆道胰腺内镜检查相关不良事件的大规模多中心研究分析
D G Adler,K Cox,M Milliken et al.
D G Adler et al.
Aim: Cholangiopancreatoscopy (CP) is an endoscopic technique that allows for direct visualization of the biliary and pancreatic ducts using a narrow caliber endoscope that passes through the working channel of a duodenosc...
Multicenter Study
Minerva gastroenterologica e dietologica. 2015 Dec;61(4):179-84. DOI: 2015
Celiac disease, non-celiac gluten sensitivity and inflammatory bowel disease [0.03%]
乳糜泻、非乳糜泻麦胶敏感和炎症性肠病
G Casella,C Di Bella,M Salemme et al.
G Casella et al.
Celiac disease (CD) and inflammatory bowel disease (IBD), such as Crohn's disease (CrD) and ulcerative colitis (UC), are chronic inflammatory condition of the gastro-intestinal tract. The prevalence of IBD in celiac patients has been report...
Update on hepatitis C: epidemiology, treatment and resistance to antiviral therapies [0.03%]
丙型肝炎的最新进展：流行病学、治疗及抗病毒药物耐药性问题
E Ness,K V Kowdley
E Ness
Chronic hepatitis C (HCV) is a major cause of morbidity and mortality due to chronic liver disease worldwide. Exposure to the virus leads to chronic infection in the majority of cases and may be associated with progression to cirrhosis, end...